Latest News

Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more
Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more

June 13th 2025

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

FDA expands glecaprevir/pibrentasvir indication for acute hepatitis C down to 3 years of age | Image credit: Contemporary Pediatrics
FDA expands glecaprevir/pibrentasvir indication for acute hepatitis C down to 3 years of age

June 12th 2025

Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD

June 12th 2025

Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention

June 10th 2025

FDA approves clesrovimab to protect infants during first RSV season | Image Credit: Contemporary Pediatrics
FDA approves clesrovimab to protect infants during first RSV season

June 9th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.